首页 | 本学科首页   官方微博 | 高级检索  
检索        

危重病评分系统预测急性肾损伤患者预后优于RIFLE分级
引用本文:杨妍姣,谢琼虹,许钟烨,匡鼎伟,刘骏峰,游怀舟,周莹,赖凌云,郑寅,顾勇,郝传明,林善锬,丁峰.危重病评分系统预测急性肾损伤患者预后优于RIFLE分级[J].中国血液净化,2010,9(7):364-367.
作者姓名:杨妍姣  谢琼虹  许钟烨  匡鼎伟  刘骏峰  游怀舟  周莹  赖凌云  郑寅  顾勇  郝传明  林善锬  丁峰
作者单位:复旦大学附属华山医院肾脏科,上海,200040
基金项目:上海市科学技术委员会课题,国家自然科学基金,复旦大学附属华山医院科研启动基金 
摘    要:目的评价并比较序贯性脏器衰竭评分(sequential organ failure assessment,SOFA)、急性生理学与慢性健康状况评分(acute physiology and chronic health evaluation,APACHE)Ⅱ、简明急性生理学评分(simplified acute physiology score,SAPS)Ⅱ和Liano评分4种危重病评分系统及RIFLE标准对急性肾损伤(acute kidney injury,AKI)患者的预后评估价值。方法本研究为前瞻性、单中心研究,收集2008年12月到2009年11月复旦大学附属华山医院各种病因引起的AKI患者。AKI的诊断标准为RIFLE的肌酐标准,除外肾后性、肾小球性、肾血管性和间质性肾炎等引起的急性损伤。研究的主要终点是28d死亡率。比较存活组和死亡组的RIFLE分级、SOFA、APACHEⅡ、SAPSⅡ和Liano评分,并进行各种评分系统对死亡的ROC曲线分析,同时将4种评分方法根据RIFLE分级进行分层分析。结果共入选194例符合入选标准的AKI患者。存活组和死亡组的RIFLE分级、AKI病因、是否需要透析差异无统计学意义(P0.05)。死亡组的机械通气比例、SOFA、APACHEⅡ、SAPSⅡ和Liano评分显著高于存活组(P0.001)。SOFA、APACHEⅡ、SAPSⅡ和Liano评分预测死亡的受试者工作特性(ROC)曲线下面积分别为0.900、0.885、0.888、0.875(均P0.001),而RIFLE的ROC曲线下面积为0.566(P0.05)。按AKI的RIFLE级别进行分层分析时发现,4个评分方法在衰竭组(Fc)ROC曲线下面积最大,其中又以Liano评分最高。结论 RIFLE分级对AKI患者的预后无明显的判断价值,而危重病评分包括SOFA、APACHEⅡ、SAPSⅡ和Liano评分对AKI的预后具有良好的预测价值。

关 键 词:急性肾损伤  RIFLE标准  危重病评分  预后  受试者工作特性曲线

General or AKI-specific scoring systems are superior to RIFLE criteria for predicting prognosis in acute kidney injury patients
YANG Yan-jiao,XIE Qiong-hong,XU Zhong-ye,KUANG Ding-wei,LIU Jun-feng,YOU Huai-zhou,ZHOU Ying,LAI Ling-yun,ZHENG Yin,GU Yong,HAO Chuan-ming,LIN Shan-yan,DING Feng.General or AKI-specific scoring systems are superior to RIFLE criteria for predicting prognosis in acute kidney injury patients[J].Chinese Journal of Blood Purification,2010,9(7):364-367.
Authors:YANG Yan-jiao  XIE Qiong-hong  XU Zhong-ye  KUANG Ding-wei  LIU Jun-feng  YOU Huai-zhou  ZHOU Ying  LAI Ling-yun  ZHENG Yin  GU Yong  HAO Chuan-ming  LIN Shan-yan  DING Feng
Institution:.( Division of Nephrology, Huashan Hospital, Fudan University, Shanghai 200040, China )
Abstract:Objective To evaluate the value of the three general scoring systems (SOFA, APACHE Ⅱ and SAPS Ⅱ), the AKI-specific scoring system (Liano), and the RILFE criteria for predicting prognosis in acute kidney injury (AKI) patients. Methods In this prospective and single center study, AKI patients with different causes and hospitalized in this hospital from December 2008 to November 2009 were enrolled. AKI was diagnosed based on the serum creatinine of RIFLE criteria. Patients were excluded from this study if the AKI was due to obstructive uropathy, interstitial nephritis, primary or secondary glomerulonephritis. The primary end point of the study was the mortality after 28 days. Scores from RIFLE classification, SOFA, APACHE Ⅱ, SAPS Ⅱ and Liano scoring systems were compared between the survival and non-survival patients. Receiver operating characteristic (ROC) curve for predicting death was used for the evaluation of scoring systems with and without stratification based on RIFLE classification. Results A total of 194 AKI patients were enrolled in this study. No significant differences were found in RIFLE classification, cause of AKI and dialysis between survivor and death groups. However, ventilation therapy, and scores from SOFA, APACHE Ⅱ, SAPS Ⅱ and Liano systems were significantly different between survivors and non-survivors. Area under ROC (AUROC) curves for predicting death by SOFA, APACHE Ⅱ, SAPS Ⅱ and Liano scores were 0.900, 0.885, 0.888 and 0.875, respectively (P0.001), which were all higher than the AUROC of RIFLE (0.566, P〉0.05). Stratification of AKI based on RIFLE classification revealed that patients in the failure group had higher AUROC of the 4 scoring systems, especially the AUROC of Liano scoring system. Conclusions General or AKI-specific scoring systems including SOFA, APACHE Ⅱ, SAPS Ⅱ and Liano systems are superior to RIFLE criteria for predicting prognosis in AKI patients.
Keywords:Acute kidney injury  RIFLE criteria  Severity scoring system  Prognosis  Receiver operating characteristic curve
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号